2026年,13家顶级生物制药公司采用了Veeva Link Key People, 进行AI驱动的客户参与,提高数据准确性和患者结果。 In 2026, 13 top biopharma firms adopted Veeva Link Key People for AI-driven customer engagement, boosting data accuracy and patient outcomes.

2026年,世界前20个生物制药公司中有13家采用Veeva Link Key People作为客户参与和AI倡议的全球标准。 In 2026, 13 of the world’s top 20 biopharmaceutical companies adopted Veeva Link Key People as their global standard for customer engagement and AI initiatives. 该平台提供保健专业人员的结构化数据,并与Veeva的数据云和共同数据架构相结合,使医疗、商业和分析团队能够更好地作出决策。 The platform provides structured data on healthcare professionals, integrated with Veeva’s Data Cloud and Common Data Architecture, enabling better decision-making across medical, commercial, and analytics teams. 最近的升级包括AI动力摘要、个性化警报和新的数据API。 Recent upgrades include AI-powered summaries, personalized alerts, and a new data API. Bayer AG等公司正在将该工具嵌入其核心数据系统,以提高AI的准确性和以患者为重点的结果。 Companies like Bayer AG are embedding the tool into their core data systems to improve AI accuracy and patient-focused outcomes. 收养人数继续增加,去年有38名新客户,包括几家顶级公司,反映出生命科学产业转向数据驱动的创新。 Adoption continues to grow, with 38 new customers in the past year, including several top-tier firms, reflecting a shift toward data-driven innovation in the life sciences industry.